In the latest trading session,, 0.45 million Adaptive Biotechnologies Corp (NASDAQ:ADPT) shares changed hands as the company’s beta touched 1.83. With the company’s most recent per share price at $11.4 changed hands at -$0.25 or -2.15% at last look, the market valuation stands at $1.73B. ADPT’s current price is a discount, trading about -9.04% off its 52-week high of $12.43. The share price had its 52-week low at $3.30, which suggests the last value was 71.05% up since then. When we look at Adaptive Biotechnologies Corp’s average trading volume, we note the 10-day average is 3.18 million shares, with the 3-month average coming to 2.31 million.
Analysts gave the Adaptive Biotechnologies Corp (ADPT) stock a consensus recommendation rating of Hold, calculated at a mean rating of 1.25. If we narrow down to specifics, the data shows that 1 out of 11 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended ADPT as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
Instantly ADPT was in red as seen in intraday trades today. With action 7.04%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 229.48%, with the 5-day performance at 7.04% in the green. However, in the 30-day time frame, Adaptive Biotechnologies Corp (NASDAQ:ADPT) is 19.75% up. Looking at the short shares, we see there were 8.93 million shares sold at short interest cover period of 7.32 days.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 18.57% from its recent market value. According to analyst projections, ADPT’s forecast low is 5 with 18 as the target high. To hit the forecast high, the stock’s price needs a -57.89% plunge from its current level, while the stock would need to tank 56.14% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -1.51%. The 2025 estimates are for Adaptive Biotechnologies Corp earnings to increase by 21.47%, but the outlook for the next 5-year period is at 30.19% per year.
ADPT Dividends
Adaptive Biotechnologies Corp is expected to release its next quarterly earnings report on 2025-May-01.
Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.35% of Adaptive Biotechnologies Corp shares while 98.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 100.72%. There are 98.36% institutions holding the Adaptive Biotechnologies Corp stock share, with VIKING GLOBAL INVESTORS LP the top institutional holder. As of 2024-06-30, the company held 20.3466% of the shares, roughly 29.99 million ADPT shares worth $108.58 million.
RUBRIC CAPITAL MANAGEMENT LP holds the second largest percentage of outstanding shares, with 9.4971% or 14.0 million shares worth $50.68 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and ARK ETF Trust-ARK Genomic Revolution ETF . With 4.49 shares estimated at $51.26 million under it, the former controlled 2.95% of total outstanding shares. On the other hand, ARK ETF Trust-ARK Genomic Revolution ETF held about 2.84% of the shares, roughly 4.32 shares worth around $49.32 million.
